Download PDF
Fortschr Neurol Psychiatr 2016; 84(05): 271-280
DOI: 10.1055/s-0042-104194
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Klinische Phänomenologie der Autoimmunenzephalitiden

Clinical Phenomenology of Autoimmune Encephalitis
J. F. Holle
1   Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Köln
2   Klinik und Poliklinik für Neurologie, Universitätsklinikum Köln
,
F. Jessen
1   Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Köln
3   DZNE-Standort Bonn, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn
,
J. Kuhn
1   Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Köln
4   Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Johanniter Krankenhaus Oberhausen
› Author Affiliations
Further Information

Publication History

Publication Date:
14 June 2016 (online)

    Permissions and Reprints

Zusammenfassung

Antikörperassoziierte Störungen des zentralen Nervensystems bilden eine heterogene Gruppe von Erkrankungen, die grob in zwei Kategorien unterteilt werden können: klassische paraneoplastische Syndrome mit sogenannten onkoneuralen Antikörpern (paraneoplastic neurological disorders, PND) und autoimmune Störungen mit Antikörpern gegen Antigene der neuronalen Oberflächen und Synapsen (autoimmune Enzephalitis, AE). Die Entdeckung der Autoimmunenzephalitiden hat zu einem Paradigmenwechsel in der Diagnose und Therapie sowie einer Reklassifizierung einiger neuropsychiatrischer Syndrome geführt, die zuvor als idiopathisch eingeordnet oder lediglich mit deskriptiven Begriffen belegt wurden.

In diesem Übersichtsartikel soll besonders auf klinisch-syndromale Aspekte der Autoimmunenzephalitiden eingegangen werden, da es diesbezüglich innerhalb der letzten zehn Jahre einen rasanten Wissenszuwachs gegeben hat, man zudem zunehmend Overlap-Syndrome und Assoziationen zu anderen Krankheitsentitäten feststellt. Neben allgemeinen Aspekten werden Charakteristika der anti-NMDAR-, anti-LGI1-, anti-GABAA und GABABR-, anti-AMPAR-, anti-CASPR2-, anti-mGluR-, anti-GlycinR-, anti-GAD-, anti-DPPX- und anti-D2R-Enzephalitis sowie der anti-IgLON5-Enzephalopathie dargestellt.

Abstract

Antibody-associated disorders of the central nervous system constitute a heterogeneous group of disorders that can be roughly divided into two categories: Classic paraneoplastic syndromes associated with so-called well-characterized antibodies (paraneoplastic neurological disorders, PND) and autoimmune disorders with antibodies to membrane-bound or synaptic antigens (autoimmune encephalitis, AE). The discovery of autoimmune encephalitis has led to a paradigm shift in diagnosis and therapy as well as a reclassification of some neuropsychiatric syndromes that were previously classified as idiopathic or simply covered with descriptive terms.

In this review article, especially clinical aspects of autoimmune encephalitis will be discussed, as there has been a rapid increase in knowledge in this regard within the past decade; increasingly overlap syndromes and associations with other disease entities have been detected. In addition to general aspects, characteristics of anti-NMDAR-, anti-LGI1-, anti-GABAA and GABABR, anti-AMPAR-, anti-CASPR2-, anti-mGluR, anti-GlycinR-, anti-GAD, anti- DPPX- and anti-D2 R encephalitis and the anti-IgLON5 encephalopathy will be presented.

Schlüsselwörter

Autoimmunenzephalitis - paraneoplastisch - neuronale Oberflächen-Antikörper - klinische Charakteristik - Herpes-simplex-Enzephalitis

Key words

autoimmune encephalitis - paraneoplastic - neuronal surface antibodies - clinical characteristics - herpes simplex encephalitis
 

  • Literatur

  • 1 Andrade DM, Tai P, Dalmau J et al. Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis. Neurology 2011; 76: 1355-1357
    CrossrefPubMedGoogle Scholar
  • 2 Armangue T, Leypoldt F, Dalmau J. Auto-immune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol 2014; 27: 361-368
    CrossrefPubMedGoogle Scholar
  • 3 Armangue T, Leypoldt F, Malaga I et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 2014; 75: 317-323
    CrossrefPubMedGoogle Scholar
  • 4 Armangue T, Titulaer MJ, Mmalaga I et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis – clinical analysis and novel findings in a series of 20 patients. J Pediatr 2013; 162: 850-856
    CrossrefPubMedGoogle Scholar
  • 5 Baizabal-Carvallo JF, Stocco A, Muscal E et al. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord 2013; 28: 543-547
    CrossrefPubMedGoogle Scholar
  • 6 Bataller L, Galiano R, Garcia-Escrig M et al. Reversible paraneoplastic limbic encephalitis associated with antibodies tot he AMPA receptor. Neurology 2010; 74: 265-267
    CrossrefPubMedGoogle Scholar
  • 7 Bayreuther C, Bourg V, Dellamonica J et al. Complex partial status epilepticus revealing anti-NMDA receptor encephalitis. Epileptic Disord 2009; 11: 261-265
    PubMedGoogle Scholar
  • 8 Boronat A, Gelfand JM, Gresa-Arribas N et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of kv4.2 potassium channels. Ann Neurol 2013; 73: 120-128
    CrossrefPubMedGoogle Scholar
  • 9 Boronat A, Sabater L, Saiz A et al. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD associated neurological disorders. Neurology 2011; 76: 795-800
    CrossrefPubMedGoogle Scholar
  • 10 Brierley JB, Corsellis JAN, Hierons R et al. Subacute encephalitis of later adult life mainly affecting the limbic areas. Brain 1960; 83: 357-368
    CrossrefPubMedGoogle Scholar
  • 11 Burton AR, Vincent E, Arnold PY et al. On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes 2008; 57: 1321-1330
    CrossrefPubMedGoogle Scholar
  • 12 Busse S, Busse M, Brix B et al. Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients. Eur Arch Psychiatry Clin Neurosci 2014; 264: 545-550
    CrossrefPubMedGoogle Scholar
  • 13 Carr I. The Ophelia syndrome: memory loss in Hodgkin´s disease. Lancet 1982; 1: 844-845
    PubMedGoogle Scholar
  • 14 Carvajal-Gonzalez A, Leite MI, Waters P et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain 2014; 137: 2178-2192
    CrossrefPubMedGoogle Scholar
  • 15 Collison K, Rees J. Asymmetric cerebellar ataxia and limbic encephalitis as a presenting feature of primary Sjogren´s syndrome. J Neurol 2007; 254: 1609-1611
    CrossrefPubMedGoogle Scholar
  • 16 Corsellis JA, Goldberg GJ, Norton AR. „Limbic encephalitis“ and ist association with carcinoma. Brain 1968; 91: 481-496
    CrossrefPubMedGoogle Scholar
  • 17 Dale RC, Merheb V, Pillai S et al. Antibodies to surface dopamine-2-receptor in autoimmune movement and psychiatric disorders. Brain 2012; 135: 3453-3468
    CrossrefPubMedGoogle Scholar
  • 18 Dalmau J, Rosenfeld MR. Autoimmune encephalitis update. Neuro-Oncology 2014; 16: 771-778
    PubMedGoogle Scholar
  • 19 De Camilli P, Thomas A, Cofiell R et al. The synaptic vesicle-associated protein amphiphysin ist the 128-kD autoantigen of Stiff-Man syndrome with breast cancer. J Exp Med 1993; 178: 2219-2223
    CrossrefPubMedGoogle Scholar
  • 20 Florance NR, Davis RL, Lam C et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neuol 2009; 66: 11-18
    PubMedGoogle Scholar
  • 21 Fujita K, Yuasa T, Watanabe O et al. Voltage-gated potassium channel complex antibodies in Creutzfeldt-Jakob disease. J Neurol 2012; 259: 2249-2250
    CrossrefPubMedGoogle Scholar
  • 22 Fukata Y, Adesnik H, Iwanaga T et al. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulöate synaptic transmission. Science 2006; 313: 1792-1795
    CrossrefPubMedGoogle Scholar
  • 23 Fukata Y, Lovero KL, Iwanaga T et al. Disruption of LGI1-linked synaptic complex causes abnormal synpatic transmission and epilepsy. Proc Natl Acad Sci USA 2010; 107: 3799-3804
    CrossrefPubMedGoogle Scholar
  • 24 Gabilondo I, Saiz A, Galan L et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology 2011; 77: 996-999
    CrossrefPubMedGoogle Scholar
  • 25 Gable MS, Gavali S, Radner A et al. Anti-NMDA receptor encephalitis: report oft ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009; 28: 1421-1429
    CrossrefPubMedGoogle Scholar
  • 26 Gable MS, Sheriff H, Dalmau J et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012; 54: 899-904
    CrossrefPubMedGoogle Scholar
  • 27 Graus F, Boronat A, Xifro X et al. The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology 2010; 74: 857-859
    CrossrefPubMedGoogle Scholar
  • 28 Gregor A, Albrecht B, Bader I et al. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1. BMC Med Genet 2011; 12: 106
    CrossrefPubMedGoogle Scholar
  • 29 Gresa-Arribas N, Titulaer MJ, Torrents A et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2013; 13: 167-177
    PubMedGoogle Scholar
  • 30 Gultekin SH, Rosenfeld MR, Voltz R et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123: 1481-1494
    CrossrefPubMedGoogle Scholar
  • 31 Hacohen Y, Deiva K, Pettingill P et al. N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord 2014; 29: 90-96
    CrossrefPubMedGoogle Scholar
  • 32 Hammer C, Stepniak B, Schneider A et al. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry 2014; 19: 1143-1149
    CrossrefPubMedGoogle Scholar
  • 33 Hofberger R, Titulaer MJ, Sabater L et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 2013; 81: 1500-1506
    CrossrefPubMedGoogle Scholar
  • 34 Hughes EG, Peng X, Gleichman AJ et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010; 30: 5866-5875
    CrossrefPubMedGoogle Scholar
  • 35 Hutchinson M, Waters P, McHugh J et al. Progressive encephalomyelitis, rigidity and myoclonus: a novel glycin receptor antibody. Neurology 2008; 71: 1291-1292
    CrossrefPubMedGoogle Scholar
  • 36 Irani SR, Alexander S, Waters P et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 proteins and contactin-associated protein-2 in limbic encephalitis, Morvan´s syndrome and acquired neuromyotonia. Brain 2010; 133: 2734-2748
    CrossrefPubMedGoogle Scholar
  • 37 Irani SR, Michell AW, Lang B et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011; 69: 892-900
    CrossrefPubMedGoogle Scholar
  • 38 Iranzo A, Graus F, Clover L et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol 2006; 59: 178-181
    CrossrefPubMedGoogle Scholar
  • 39 Ishida K, Mitoma H, Mizusawa H. Rversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies. J Neurol Sci 2008; 271: 186-190
    CrossrefPubMedGoogle Scholar
  • 40 Jarius S, Hoffmann L, Clover L et al. CSF findings in patients with voltage-gated potassium channel antibody associated limbic encephalitis. J Neurol Sci 2008; 68: 74-77
    PubMedGoogle Scholar
  • 41 Johnson N, Henry C, Fessler AJ et al. Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 2010; 75: 1480-1482
    CrossrefPubMedGoogle Scholar
  • 42 Jarius S, Steinmeyer F, Knobel A et al. GABAB receptor antibodies in paraneoplastic cerebellar ataxia. J Neuroimmunol 2013; 256: 94-96
    CrossrefPubMedGoogle Scholar
  • 43 Jeffery OJ, Lennon VA, Pittock SJ et al. GABAB receptor autoantibody frequency in service serologic evaluation. Neurology 2013; 81: 882-887
    CrossrefPubMedGoogle Scholar
  • 44 Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis in psychiatry. Curr Psychiatry Rev 2011; 7: 189-193
    CrossrefPubMedGoogle Scholar
  • 45 Kayser MS, Dalmau J. The emerging link between autoimmune disorders and neuropsychiatric disease. J Neuropsychiatry Clin Neurosci 2011; 23: 90-97
    CrossrefPubMedGoogle Scholar
  • 46 Kayser MS, Titulaer MJ, Gresa-Arribas N et al. Frequency and characteristics of isolated psychiatric episodes in anti-methyl-d-aspartate receptor encephalitis JAMA Neurol. 2013; 70: 1133-1139
    PubMedGoogle Scholar
  • 47 Kleinig TJ, Thompson PD, Matar W et al. The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 2008; 23: 1256-1261
    CrossrefPubMedGoogle Scholar
  • 48 Kramme C, Bien CG. Immune-mediated epilepsy and encephalopathy. Nervenarzt 2013; 84: 442-449
    CrossrefPubMedGoogle Scholar
  • 49 Kumar MA, Jain A, Dechant VE et al. Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy. Arch Neurol 2010; 67: 884-887
    PubMedGoogle Scholar
  • 50 Lai M, Hughes EG, Peng X et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009; 65: 424-434
    CrossrefPubMedGoogle Scholar
  • 51 Lai M, Huijbers MG, Lancaster E et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010; 9: 776-785
    CrossrefPubMedGoogle Scholar
  • 52 Lancaster E, Dalmau J. Neuronal autoantigens – pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012; 8: 380-390
    CrossrefPubMedGoogle Scholar
  • 53 Lancaster E, Huijbers MG, Bar V et al. Investigations of Caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011; 69: 303-311
    CrossrefPubMedGoogle Scholar
  • 54 Lancaster E, Lai M, Peng X et al. Antibodies tot he GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation oft he antigen. Lancet Neurol 2010; 9: 67-76
    CrossrefPubMedGoogle Scholar
  • 55 Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011; 77: 179-189
    CrossrefPubMedGoogle Scholar
  • 56 Lancaster E, Martinez-Hernandez E, Titulaer MJ et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 2011; 77: 1698-1701
    CrossrefPubMedGoogle Scholar
  • 57 Lee M, Lawn N, Prentice D et al. Anti-NMDA receptor encephalitis associated with ictal asystole. J Clin Neurosci 2011; 18: 1716-1718
    CrossrefPubMedGoogle Scholar
  • 58 Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann NY Acad Sci 2015; 1338: 94-114
    CrossrefPubMedGoogle Scholar
  • 59 Leypoldt F, Titulaer MJ, Aguilar E et al. Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report. Neurology 2013; 81: 1637-1639
    CrossrefPubMedGoogle Scholar
  • 60 Marignier R, Chenevier F, Rogemond V et al. Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?. Arch Neurol 2010; 67: 627-630
    PubMedGoogle Scholar
  • 61 Mas N, Saiz A, Leite MI et al. Anti-glycine receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 2011; 82 (12) 1399-1401
    CrossrefPubMedGoogle Scholar
  • 62 Mat A, Adler H, Merwick A et al. Ophelia syndrome with metabotropic glutamate receptor 5 antibodies in CSF. Neurology 2013; 80: 1349-1350
    CrossrefPubMedGoogle Scholar
  • 63 McKeon A, Martinez-Hernandez E, Lancaster E et al. Glycin receptor autoimmune spectrum with stiff-man syndrome phenotype. Arch Neurol 2013; 70: 44-50
    PubMedGoogle Scholar
  • 64 McKeon A, Robinson MT, McEvoy KM et al. Stiff-man syndrome and variants: clinical course, treatments and outcomes. Arch Neurol 2012; 69 (02) 230-238
    CrossrefPubMedGoogle Scholar
  • 65 Millichap JJ, Goldstein JL, Laux LC et al. Ictal asystole and anti-N-methyl-D-aspartate receptor antibody encephalitis. Pediatrics 2011; 127: e781-e786
    CrossrefPubMedGoogle Scholar
  • 66 Mundiyanapurath S, Jarius S, Probst C et al. GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis. J Neuroimmunol 2013; 259: 88-91
    CrossrefPubMedGoogle Scholar
  • 67 Nadal MS, Ozaita A, Amarillo Y et al. The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a critical component of neuronal A-type K+ channels. Neuron 2003; 37 (03) 449-461
    CrossrefPubMedGoogle Scholar
  • 68 Paterson RW, Zandi MS, Armstrong R et al. Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre. J Neurol Neurosurg Psychiatry 2014; 85: 625-630
    CrossrefPubMedGoogle Scholar
  • 69 Petit-Pedrol M, Armangue T, Peng X et al. Encephalitis with refractory seizures, status epilepticus and antibodies tot he GABA(A) receptor: a case series, charactzerization oft he antigen and analysis oft he effect of antibodies. Lancet Neurol 2014; 13 (03) 276-286
    CrossrefPubMedGoogle Scholar
  • 70 Pettinghill P, Kramer H, Coebergh JA et al. Antibodies to GABAA receptor α1 and ɣ2 subunits. Neurology 2015; 84: 1233-1241
    CrossrefPubMedGoogle Scholar
  • 71 Piepgras J, Höltje M, Michel K et al. Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons. Neurology 2015; 85 (10) 890-897
    CrossrefPubMedGoogle Scholar
  • 72 Pittock SJ, Luccinetti CF, Parisi JE et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 2005; 58 (01) 96-107
    CrossrefPubMedGoogle Scholar
  • 73 Pollak TA, McCormack R, Peakman M et al. Prevalence of anti-N-methyl-D-aspartate (NMDA) antibodies in patients with schizophrenia and related psychosis: a systematic review and meta-analysis. Psychol Med 2014; 44: 2475-2487
    CrossrefPubMedGoogle Scholar
  • 74 Prüss H. Neuroimmunology: New developments in limbic encephalitis. Akt Neurology 2013; 40: 127-136
    PubMedGoogle Scholar
  • 75 Prüss H, Dalmau J, Harms L et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 2010; 75 (19) 1735-1739
    CrossrefPubMedGoogle Scholar
  • 76 Prüss H, Finke C, Höltje M et al. N-Methyl-Aspartate Receptor Antibodies in Herpes Simplex Encephalitis. Ann Neurol 2012; 72 (06) 902-911
    CrossrefPubMedGoogle Scholar
  • 77 Raju R, Foote J, Banga JP et al. Analysis of GAD65 autoantibodies in stiff-person syndrome patients. J Immunol 2005; 175 (11) 7755-7762
    CrossrefPubMedGoogle Scholar
  • 78 Rosenkranz SC, Friese MA. Autoimmune Enzephalitiden. Info Neurologie und Psychiatrie 2015; 17: 38-45
    PubMedGoogle Scholar
  • 79 Sabater L, Gaig C, Gelpi E et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation oft he antigen and post-mortem study. Lancet Neurol 2014; 13: 575-586
    CrossrefPubMedGoogle Scholar
  • 80 Sabater L, Titulae M, Saiz A et al. SOX1 antibodies are markers of paraneoplastic Lambert Eaton myasthenic syndrome. Neurology 2007; 70 (12) 4260-4267
    PubMedGoogle Scholar
  • 81 Saiz A, Blanco Y, Sabater L et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008; 131 (10) 2553-2563
    CrossrefPubMedGoogle Scholar
  • 82 Saiz A, Dalmau J, Butler MH et al. Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with smll cell lung carcinoma. J Neurol Neurosurg Psychiatrie 1999; 66: 214-217
    PubMedGoogle Scholar
  • 83 Sansing LH, Tuzun E, Ko MW et al. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007; 3: 291-296
    CrossrefPubMedGoogle Scholar
  • 84 Scheid R, Voltz R, Vetter T et al. Neurosyphilis and paraneoplastic limbic encephalitis: important differential diagnosis. J Neurol 2005; 252: 1129-1132
    CrossrefPubMedGoogle Scholar
  • 85 Schleede L, Bueter W, Baumgartner-Sigl S et al. Pediatric herpes simplex virus encephalitis: a retrospective multicenter experience. J Child Neurol 2013; 28 (03) 321-331
    CrossrefPubMedGoogle Scholar
  • 86 Schmitt SE, Pargeon K, Frechette ES et al. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012; 79: 1094-1100
    CrossrefPubMedGoogle Scholar
  • 87 Sillevis SP, Kinoshita A, De Leeuw B et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 2000; 342 (01) 21-27
    CrossrefPubMedGoogle Scholar
  • 88 Skoldenberg B, Aurelius E, Hjalmarsson A et al. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol 2006; 253 (02) 163-170
    PubMedGoogle Scholar
  • 89 Stubgen JP. Nervous system lupus mimics limbic encephalitis. Lupus 1998; 7: 557-560
    CrossrefPubMedGoogle Scholar
  • 90 Titulaer MJ, Dalmau J. Antibodies to NMDA receptor, blood-brain barrier disruption and schizophrenia: a theory with unproven links. Mol Psychiatry 2014; 19: 1054
    PubMedGoogle Scholar
  • 91 Titulaer M, Hoftberger R, Iizuka T et al. Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis. Ann Neurol 2014; 75 (03) 411-428
    CrossrefPubMedGoogle Scholar
  • 92 Titulaer MJ, McCracken L, Gabilondo I et al. Late-onset anti-NMDA receptor Encephalitis. Neurology 2013; 81 (12) 1058-1063
    CrossrefPubMedGoogle Scholar
  • 93 Titulaer MJ, McCracken L, Gabilondo I et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12 (02) 157-165
    CrossrefPubMedGoogle Scholar
  • 94 Turner MR, Irani SR, Leite MI et al. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology 2011; 77: 439-443
    CrossrefPubMedGoogle Scholar
  • 95 Uchino A, Iizuka T, Urano Y et al. Pseudo-piano playing motions and nocturnal hypoventilation in anti-NMDA receptor encephalitis: response to prompt tumor removal and immunotherapy. Intern Med 2011; 50: 627-630
    CrossrefPubMedGoogle Scholar
  • 96 Verkerk AJ, Mathews CA, Joosse M et al. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 2003; 82 (01) 1-9
    CrossrefPubMedGoogle Scholar
  • 97 Wainwright MS, Martin PL, Morse RP et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001; 50: 612-619
    CrossrefPubMedGoogle Scholar
  • 98 Zandi MS, Irani SR, Lang B et al. Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 2011; 258: 686-688
    CrossrefPubMedGoogle Scholar